Newport Beach, CALIFORNIA4 Active Studies

Leukemia Clinical Trials in Newport Beach, CALIFORNIA

Find 4 actively recruiting leukemia clinical trials in Newport Beach, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,157
Enrolling

Recruiting Leukemia Studies in Newport Beach

RecruitingNewport Beach, CALIFORNIANCT06875310

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet chemotherapy versus placebo plus pembrolizumab plus platinum-doublet chemothera...

630 participants
Mirati Therapeutics Inc.
View Study Details
RecruitingNewport Beach, CALIFORNIANCT04988555

A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation

A phase 1/2 dose escalation / dose expansion study of Enzomenib (DSP-5336) in adult patients with acute leukemia....

362 participants
Sumitomo Pharma America, Inc.
View Study Details
RecruitingNewport Beach, CALIFORNIANCT06362252

A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

This study is designed to evaluate the safety and efficacy of ifinatamab deruxtecan (I-DXd) in combination with immune checkpoint inhibitor (ICI) atezolizumab with or without carboplatin in participan...

123 participants
Daiichi Sankyo
View Study Details
RecruitingNewport Beach, CALIFORNIANCT05198830

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

This phase II trial tests whether TRC102 (methoxyamine hydrochloride) in combination usual care treatment comprised of pemetrexed, cisplatin or carboplatin, and radiation therapy followed by durvaluma...

42 participants
National Cancer Institute (NCI)
View Study Details

About Leukemia Clinical Trials in Newport Beach

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 4 leukemia clinical trials recruiting participants in Newport Beach, CALIFORNIA. These studies are seeking a combined 1,157 participants. Research is being sponsored by Mirati Therapeutics Inc., Sumitomo Pharma America, Inc., Daiichi Sankyo and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Newport Beach — FAQ

Are there leukemia clinical trials in Newport Beach?

Yes, there are 4 leukemia clinical trials currently recruiting in Newport Beach, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Newport Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newport Beach research site will contact you about next steps.

Are clinical trials in Newport Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newport Beach studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 4 active trials in Newport Beach are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated March 2, 2026 from ClinicalTrials.gov